Category - Pharma Industry News
GSK discontinues two feladilimab trials in head and neck cancer
Alchemab completes £60m Series A funding to advance novel antibody platform
Magic mushroom compound psilocybin shows ‘promise’ in depression
Amylyx Pharma plans to file ALS therapy with the EMA this year
GSK decides to halt mid-stage feladilimab studies
BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
UK trial evaluating mixed-vaccine regimens includes two more jabs
Moderna’s booster vaccine for South African variant demonstrates promising early results